JPM vs MCO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Moody's Corporation (MCO) exhibits exceptional profitability and consistent earnings execution, underpinned by best-in-class margins and ROE of 54.91%, significantly outperforming financial services peers. Despite a premium valuation (P/E 38.6x vs sector 20.6x), the stock is supported by robust 22.9% YoY earnings growth, strong cash flow generation, and a favorable analyst target of $543.75 implying 13.4% upside. Price momentum has lagged recently (1Y: +0.2%, 6M: -1.8%), but long-term performance remains strong (5Y: +81.5%), reflecting durable franchise value in credit ratings and analytics. Insider selling introduces caution, though it appears routine rather than distress-driven, while the analyst community maintains a unified 'buy' recommendation.
Compare Another Pair
Related Comparisons
JPM vs MCO: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Moody's Corporation (MCO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.